Recent industry reports have highlighted past and projected rapid expansion in the DNA diagnostics and genomics markets, driven by liquid biopsies, direct-to-consumer testing, and personalized ...

Illumina, Commercial Metals and Newmont stand out as brokers boost ratings amid inflation concerns and shifting economic signals.

The DNA Diagnostics Market is set to surge from USD 13.07 billion in 2024 to USD 21.69 billion by 2030, growing at a CAGR of ...

Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...

The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...

The 24th HUPO World Congress showed a field growing beyond mass spectrometry and starting to think in terms of impact of its ecosystems.

Single-cell sequencing provides unprecedented detail into cell-to-cell variability, uncovering key biological mechanisms in ...

The global genomics market is projected to expand by 15-17% by 2029. Key factors driving this growth include the increasing ...

Quest Diagnostics appoints new leader for Blueprint. Juhana Rauramo is in as vice president and general manager for Blueprint ...

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

In a significant setback for the Federal Trade Commission (FTC), the U.S. District Court for the District of Columbia ruled in favor of ...

As a prominent force in DNA sequencing and array-based technologies, Illumina has been deeply committed to China for two decades. Despite market challenges, Illumina remains steadfast in its mission ...